Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Seminars in Radiation Oncology
ISSN 1053-4296 · eISSN 1532-9461 · W.B. Saunders Ltd · UNITED STATES · Quarterly · Founded 1991
Seminars in Radiation Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.3; hybrid open access; APC about USD 3,330; median 52 days to acceptance (80 articles, last 24 months); community-reported acceptance: moderate; 57 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Radiation Oncology is published by W.B. Saunders Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Radiation Therapy and Dosimetry and Effects of Radiation Exposure, together about 29.7% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editorial board by country: none in mainland China; most named United States 12, Germany 3, Canada 2 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy16.9%
- Radiation Therapy and DosimetryMedicine6.5%
- Effects of Radiation ExposureMedicine6.3%
- Medical Imaging Techniques and ApplicationsMedicine6.3%
- Lung Cancer Diagnosis and TreatmentMedicine5.1%
- Head and Neck Cancer StudiesMedicine5%
- Prostate Cancer Diagnosis and TreatmentMedicine4.2%
- Prostate Cancer Treatment and ResearchMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.3LetPub ·
- Impact factor (publisher)
- 4.3Publisher website ·
- CiteScore 2026-06
- 6.4LetPub ·
- CiteScore (publisher)
- 6.4Publisher website ·
- SJR 2026-06
- 1.21LetPub ·
- SNIP 2026-06
- 1.15LetPub ·
- h-index
- 84LetPub ·
- h-index
- 123OpenAlex ·
- i10-index
- 1,005OpenAlex ·
- 2-year mean citedness
- 4.67OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 21.13%LetPub ·
Volume
- Articles per year
- 53LetPub ·
Articles by year OpenAlex count · 1,626 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 19 | 21 |
| 2025 | 57 | 18 | 206 |
| 2024 | 50 | 26 | 455 |
| 2023 | 50 | 22 | 627 |
| 2022 | 50 | 17 | 718 |
| 2021 | 44 | 17 | 748 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
52 daysMedian, submission to acceptance · P25–P75 31 days – 75 days
- Acceptance to online
- median 26 days (21 articles)
- Submission to online
- median 72 days
- Sample
- 80 articles with submission and acceptance dates (109 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,330 / EUR 3,120 / GBP 2,670 / JPY 413,020 | — | — | |
| Publisher website | USD 3,220 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Submissions accepted by invitation only Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1991
- ISSN
- 1053-4296
- Electronic ISSN
- 1532-9461
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Radiation Oncology
What CAS zone is Seminars in Radiation Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Radiation Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Radiation Oncology?
The latest impact factor listed by LetPub is 4.3; CiteScore 6.4, h-index 123.
How long does peer review take at Seminars in Radiation Oncology?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 52 days (interquartile range 31–75 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Seminars in Radiation Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Seminars in Radiation Oncology based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (12), Germany (3) and Canada (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Radiation Oncology?
According to LetPub and DOAJ records, Seminars in Radiation Oncology is indexed in SCIE and Scopus.
Is Seminars in Radiation Oncology open access, and what is the APC?
Seminars in Radiation Oncology is a hybrid journal. For open-access publication: APC about USD 3,330.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .